8-KFiling Date: Jun 22, 2026

AbbVie 8-K: Reg FD Disclosure, Financial Statements (Jun 22, 2026)

AbbVie Inc.

View SEC Filing

ACC: 0001104659-26-076067

Event Type

Reg FD DisclosureFinancial Statements

Filing overview

AbbVie filed a Form 8-K (Material Event (8-K)) with the SEC on 2026-06-22. Reported items: Item 7.01 Reg FD Disclosure; Item 9.01 Financial Statements.

More filings from AbbVie

Recent 8-K filings from other companies

Richtech Robotics (RR) 8-K · Oct 2, 2026Executive Change; Shareholder Vote
Pinterest (PINS) 8-K · Oct 2, 2026Level 21 CIC severance expanded
Live Nation Entertainment (LYV) 8-K · Oct 2, 2026Executive Change; Financial Statements
Teledyne Technologies (TDY) 8-K/A · Oct 2, 2026Executive Change; Financial Statements
Nano Nuclear Energy (NNE) 8-K · Oct 2, 2026Material Agreement; Securities Issuance; Reg FD Disclosure; Financial…